Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 07, 2024

Efficacy of Sacituzumab Govitecan and Trastuzumab Deruxtecan in Patients With Metastatic Breast Cancer With Stable and Active Brain Metastases

ESMO Open

 

Additional Info

ESMO Open
The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients-a multicenter real-world analysis
ESMO Open 2024 Apr 17;9(5)102995, D Dannehl, D Jakob, F Mergel, A Estler, T Engler, L Volmer, ML Frevert, S Matovina, A Englisch, CM Tegeler, A Rohner, A Seller, M Hahn, K Pfister, A Fink, I Popp, S Lorenz, G Tabatabai, I Juhasz-Böss, W Janni, S Brucker, FA Taran, A Hartkopf, H Schäffler

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading